Michael R Goldberg
Overview
Explore the profile of Michael R Goldberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1092
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elizur A, Koren Y, Appel M, Nachshon L, Levy M, Epstein-Rigbi N, et al.
J Allergy Clin Immunol Pract
. 2025 Jan;
PMID: 39800058
Background: Data on oral immunotherapy (OIT) for hazelnut allergy is limited and its potential to cross-desensitize for other nuts is unknown. Objective: To study the efficacy and safety of hazelnut...
2.
Nachshon L, Goldberg M, Epstein-Rigbi N, Katz Y, Elizur A
J Allergy Clin Immunol Pract
. 2024 Nov;
13(2):369-377.e3.
PMID: 39486514
Background: Resolution rates of IgE-mediated cow's milk allergy (IgE-CMA) by age 5 years and risk factors for its persistence were previously described. Objective: To extend follow-up until the end of...
3.
Epstein-Rigbi N, Levy M, Nachshon L, Koren Y, Goldberg M, Elizur A
Allergy Asthma Clin Immunol
. 2024 Oct;
20(1):53.
PMID: 39402617
Background: Oral immunotherapy (OIT) has become the standard of care for children with food allergy (FA) and has substantially improved their quality of life. The effect of OIT on the...
4.
Elizur A, Goldberg M
Ann Allergy Asthma Immunol
. 2024 May;
133(3):341-342.
PMID: 38777121
No abstract available.
5.
Elizur A, Goldberg M, Kessel A
J Allergy Clin Immunol Pract
. 2024 May;
12(5):1382-1383.
PMID: 38724166
No abstract available.
6.
Goldberg M, Appel M, Tobi K, Levy M, Epstein-Rigbi N, Holmqvist M, et al.
J Allergy Clin Immunol Pract
. 2024 Feb;
12(5):1273-1282.e5.
PMID: 38382880
Background: Because of the high cross-sensitization among tree nuts, the NUT CRACKER (Nut Co-reactivity-Acquiring Knowledge for Elimination Recommendations) study proposed a diagnostic algorithm to minimize the number of required oral...
7.
Goldberg M, Epstein-Rigbi N, Elizur A
Clin Rev Allergy Immunol
. 2023 Nov;
65(3):365-376.
PMID: 37957456
Gastrointestinal adverse events are common during oral immunotherapy (OIT) for food allergy and range from immediate IgE-mediated reactions to non-anaphylactic clinical presentations. This review aims to summarize recent findings on...
8.
Nachshon L, Westerhout J, Blom W, Remington B, Levy M, Goldberg M, et al.
Allergy
. 2023 Aug;
78(12):3212-3220.
PMID: 37606275
Background: Sesame is a significant food allergen causing severe and even fatal reactions. Given its increasing prevalence in western diet, sesame is listed as an allergenic food requiring labeling in...
9.
Shtossel O, Turjeman S, Riumin A, Goldberg M, Elizur A, Bekor Y, et al.
Microbiome
. 2023 Aug;
11(1):181.
PMID: 37580821
Background: Some microbiota compositions are associated with negative outcomes, including among others, obesity, allergies, and the failure to respond to treatment. Microbiota manipulation or supplementation can restore a community associated...
10.
Nachshon L, Schwartz N, Levy M, Goldberg M, Epstein-Rigbi N, Katz Y, et al.
Ann Allergy Asthma Immunol
. 2022 Dec;
130(3):340-346.e5.
PMID: 36509409
Background: Home reactions requiring epinephrine administration, a marker of their severity, restrict the widespread use of oral immunotherapy (OIT), but their risk factors are largely not known. Objective: To identify...